4 minute read
Nov. 28, 2022

BAY-069 (Bayer): a BCAT1/2 inhibitor

BAY-069

oral BCAT1/2 inhibitor favorable PK profile in rats from 788762 cmpd. HTS and SBDD J. Med. Chem. Bayer Pharma AG, Berlin, DE

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in